Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)

CUSIP: 04635X102

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
57,127,897
Total 13F shares
57,634,977
Share change
+20,754,224
Total reported value
$810,618,371
Put/Call ratio
12%
Price per share
$14.08
Number of holders
102
Value change
+$319,828,537
Number of buys
70
Number of sells
37

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 04635X102?
CUSIP 04635X102 identifies ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q1 2024

As of 31 Mar 2024, Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) was held by 102 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,634,977 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., FMR LLC, VR Adviser, LLC, BlackRock Inc., Fairmount Funds Management LLC, VANGUARD GROUP INC, Vivo Capital, LLC, and STATE STREET CORP. This page lists 102 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
78
Q1 2024 holders
102
Holder diff
24
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.